Integrating alternative therapies in overcoming chemotherapy resistance in tumors

Sana S Alqarni1, Najeeb Ullah Khan2

  • 1Department of Clinical Laboratory Science, College of Applied Medical Science, King Saud University, 11421, Riyadh, Saudi Arabia.

Molecular Biology Reports
|February 17, 2025
PubMed

Insights

Chemotherapy resistance is a major hurdle in cancer treatment. This review explores alternative therapies like immunotherapy and herbal treatments to overcome resistance and improve patient outcomes.

Area of Science:

  • Oncology
  • Cancer Therapeutics
  • Drug Resistance

Background:

  • Chemotherapy resistance in tumors poses a significant clinical challenge.
  • Mechanisms include genetic mutations, drug efflux, altered metabolism, and tumor microenvironment adaptations.
  • These factors limit treatment effectiveness and lead to tumor relapse.

Purpose of the Study:

  • To review alternative therapies for overcoming chemotherapy resistance.
  • To highlight emerging strategies and their efficacy rates.
  • To discuss the integration of alternative therapies with conventional treatments.

Main Methods:

  • Literature review of alternative cancer treatment strategies.
  • Analysis of efficacy rates for various alternative therapies.
  • Discussion of challenges and future directions in cancer therapeutics.

Main Results:

  • Alternative therapies show high efficacy: herbal (90%), photodynamic therapy/hypothermia (86-99%), immunotherapy (80%), gene therapy (67-80%), epigenetic therapies (51-89%).
  • Targeted therapies (58-64%), hormone therapy (22-61%), probiotics (34-90%), metabolic therapies (>50%), microbiome-based therapies (50%), and nanotechnology (50-67%) are also explored.
  • Integrating these with conventional treatments can improve therapeutic efficacy and patient outcomes.

Conclusions:

  • Advancements in molecular diagnostics, liquid biopsies, and biomarkers are crucial for monitoring resistance and guiding treatment.
  • Addressing tumor heterogeneity and lack of predictive biomarkers is essential.
  • Expanding clinical trials is vital for validating new therapies and improving patient survival.

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
463
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.4K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K